Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141683 |
| CAS No | NA |
| Mol.F. | C25H23FN2O4 |
| Mol.Wt. | 434.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141684 |
| CAS No | NA |
| Mol.F. | C13H11ClN6O |
| Mol.Wt. | 302.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141685 |
| CAS No | NA |
| Mol.F. | C20H19N9O4S |
| Mol.Wt. | 481.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141686 |
| CAS No | NA |
| Mol.F. | C20H20N8O3S |
| Mol.Wt. | 452.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141687 |
| CAS No | NA |
| Mol.F. | C21H26N2O6 |
| Mol.Wt. | 402.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141688 |
| CAS No | 32863-63-1 |
| Mol.F. | C13H13ClN4O |
| Mol.Wt. | 276.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141689 |
| CAS No | NA |
| Mol.F. | C13H16FN3O4 |
| Mol.Wt. | 297.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141690 |
| CAS No | NA |
| Mol.F. | C15H18FN3O4 |
| Mol.Wt. | 323.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141691 |
| CAS No | NA |
| Mol.F. | C14H18FN3O4 |
| Mol.Wt. | 311.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141692 |
| CAS No | NA |
| Mol.F. | C13H15FN2O5 |
| Mol.Wt. | 298.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141693 |
| CAS No | NA |
| Mol.F. | C20H17F4N5O3 |
| Mol.Wt. | 451.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141694 |
| CAS No | NA |
| Mol.F. | C21H15F4N5O3S |
| Mol.Wt. | 493.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141695 |
| CAS No | NA |
| Mol.F. | C7H8N2O2S |
| Mol.Wt. | 184.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141696 |
| CAS No | NA |
| Mol.F. | C9H10N2O3S |
| Mol.Wt. | 226.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141697 |
| CAS No | NA |
| Mol.F. | C21H24N2O4 |
| Mol.Wt. | 368.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141698 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S3 |
| Mol.Wt. | 400.5 |
| INV STATUS | CUSTOM SYNTHESIS |